Published in J Infect Dis on January 01, 1988
Salmonella typhimurium mutants lacking flagella or motility remain virulent in BALB/c mice. Infect Immun (1990) 1.93
Characterization and protective properties of attenuated mutants of Salmonella choleraesuis. Infect Immun (1992) 1.33
A simple screen to identify promoters conferring high levels of phenotypic noise. PLoS Genet (2008) 1.28
Salmonella flagellins are potent adjuvants for intranasally administered whole inactivated influenza vaccine. Vaccine (2009) 1.14
Host and bacterial factors affecting induction of immune responses to flagellin expressed by attenuated Salmonella vaccine strains. Infect Immun (2004) 0.89
Salmonella flagellin is not a dominant protective antigen in oral immunization with attenuated live vaccine strains. Infect Immun (2004) 0.89
Pathogenicity and protective effect of rough mutants of Salmonella species in germ-free piglets. Infect Immun (1997) 0.84
Mortality among infants of black as compared with white college-educated parents. N Engl J Med (1992) 5.65
The role of the flagellum in the adherence of Vibrio cholerae. J Infect Dis (1983) 3.91
Intestinal colonization and virulence of Salmonella in mice. Infect Immun (1978) 3.44
Sensitivity of rough gram-negative bacteria to the bactericidal action of serum. J Bacteriol (1968) 2.68
Molecular cloning and expression in Escherichia coli K-12 of the O antigens of the Inaba and Ogawa serotypes of the Vibrio cholerae O1 lipopolysaccharides and their potential for vaccine development. Infect Immun (1986) 2.36
The antigens of Vibrio cholerae involved in the vibriocidal action of antibody and complement. J Infect Dis (1970) 2.03
Sequence and analysis of chromosome 1 of the plant Arabidopsis thaliana. Nature (2000) 1.85
Experimental cholera in infant mice: protective effects of antibody. J Infect Dis (1972) 1.81
Be wary of subsidising nicotine replacement therapy. Tob Control (2002) 1.67
Number of molecules of antibody required to promote phagocytosis of one bacterium. Nature (1966) 1.65
Further studies regarding the question of cellular immunity in mouse typhoid. Aust J Exp Biol Med Sci (1968) 1.65
Lipid peroxidation in rheumatoid arthritis: thiobarbituric acid-reactive material and catalytic iron salts in synovial fluid from rheumatoid patients. Clin Sci (Lond) (1984) 1.61
Antibody cross-linking as a factor in immunity to cholera in infant mice. J Infect Dis (1975) 1.61
Development of a rating system for surgeons' non-technical skills. Med Educ (2006) 1.59
In vitro dorsal root ganglia and human prostate cell line interaction: redefining perineural invasion in prostate cancer. Prostate (2001) 1.58
Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a. Infect Immun (1990) 1.55
A chromosomal integration system for stabilization of heterologous genes in Salmonella based vaccine strains. Microb Pathog (1988) 1.54
Endotoxins and bacterial virulence. J Infect Dis (1971) 1.51
The colonization of Peyer's patches by a strain of Salmonella typhimurium cured of the cryptic plasmid. J Infect Dis (1986) 1.49
Antibody response to the lipopolysaccharide and protein antigens of Salmonella typhi during typhoid infection. I. Measurement of serum antibodies by radioimmunoassay. Clin Exp Immunol (1981) 1.49
Antibacterial mechanisms in the intestine. Elimination of V. cholerae from the intestines of infant mice and the role of antibody. Aust J Exp Biol Med Sci (1975) 1.46
The antibody response to bacterial gastroenteritis in serum and secretions. Clin Exp Immunol (1980) 1.43
Delayed antigen presentation by epidermal Langerhans cells to cloned T h1 and T h2 cells. J Invest Dermatol (1990) 1.41
Sensitization of complement resistant bacterial strains. Nature (1969) 1.40
Wood smoke exposure induces a pulmonary and systemic inflammatory response in firefighters. Eur Respir J (2008) 1.38
Construction of defined galE mutants of Salmonella for use as vaccines. J Infect Dis (1987) 1.37
Phagocytosis and immunity. The carrier state and cellular immunity. Experientia (1966) 1.36
Preparation of an artificial antigen and immunity to mouse typhoid. Immunology (1967) 1.33
Isolation and biological properties of three classes of rabbit antibody to Vibrio cholerae. J Infect Dis (1974) 1.33
Opsonic requirements for bacterial phagocytosis. Nature (1965) 1.31
Passive sensitization of Salmonella adelaide to the bactericidal action of antibody and complement. Nature (1968) 1.29
Mutations at rfc or pmi attenuate Salmonella typhimurium virulence for mice. Infect Immun (1991) 1.27
Antibacterial action of specific IgA and transport of IgM, IgA, and IgG from serum into the small intestine. J Infect Dis (1971) 1.27
Antibacterial mechanisms in the intestine. Elimination of V. cholerae from the gastrointestinal tract of adult mice. Aust J Exp Biol Med Sci (1975) 1.24
Teaching surgeons about non-technical skills. Surgeon (2007) 1.23
Cerebral and ocular toxicity induced by desferrioxamine. Q J Med (1985) 1.21
Protection against cholera. A bactericidal mechanism on the mucosal surface of the small intestine of mice. Aust J Exp Biol Med Sci (1975) 1.20
The relative antibacterial efficiency of IgM, IgG and IgA from pig colostrum. Aust J Exp Biol Med Sci (1971) 1.17
Intestinal and serum antibody responses in mice after oral immunization with Salmonella, Escherichia coli, and Salmonella-Escherichia coli hybrid strains. Infect Immun (1979) 1.17
Decreasing trends in Reye syndrome and aspirin use in Michigan, 1979 to 1984. Pediatrics (1986) 1.15
Prophylactic significance of the nonlipopolysaccharide antigens of Vibrio cholerae. J Infect Dis (1983) 1.15
Hospitalizations for severe complications of pregnancy, 1987-1992. Obstet Gynecol (1997) 1.14
Dog immunoglobulins. I. immunochemical characterization of dog serum, parotid saliva, colostrum, milk and small bowel fluid. Immunology (1975) 1.12
Maternal and perinatal mortality. Curr Opin Obstet Gynecol (1992) 1.11
Phagocytosis and immunity. The central role of phagocytosis in immune reactions. Experientia (1966) 1.10
Further evidence for cross-linking as a protective factor in experimental cholera: properties of antibody fragments. J Infect Dis (1975) 1.10
Antibody response to the lipopolysaccharide and protein antigens of Salmonella typhi during typhoid infection. II. Measurement of intestinal antibodies by radioimmunoassay. Clin Exp Immunol (1981) 1.09
Protection of infant mice against cholera by antibodies to three antigens of Vibrio cholerae. J Infect Dis (1972) 1.08
The functional heterogeneity of macrophages at the single cell level. Aust J Exp Biol Med Sci (1967) 1.05
Role of TGF-beta in immune-evasion of cancer. Microsc Res Tech (2001) 1.05
The origin of the antibody released into serum following injection of bacterial lipopolysaccharide. Aust J Exp Biol Med Sci (1967) 1.04
Dog immunoglobulins. II. The antibacterial properties of dog IgA, IgM and IgG antibodies to Vibrio cholerae. Immunology (1975) 1.02
Bacterial lipopolysaccharide-induced intestinal microvascular lesions leading to acute diarrhea. J Clin Invest (1988) 1.02
National trends in the incidence of abruptio placentae, 1979-1987. Obstet Gynecol (1991) 1.01
A quantitative comparison of the antigenic structure of a virulent and an avirulent strain of Salmonella typhimurium. Immunology (1969) 1.01
Re-examination of small intestinal disposal of Vibrio cholerae in mice. Aust J Exp Biol Med Sci (1977) 1.01
The effect of lysozyme on the complement-dependent bactericidal action of different antibody classes. Immunology (1975) 0.99
Cognitive representations of illness and functional and affective adjustment following surgery for osteoarthritis. Soc Sci Med (1998) 0.96
Resistance to Klebsiella pneumoniae and the importance of two bacterial antigens. Aust J Exp Biol Med Sci (1982) 0.96
The serum polymeric IgA antibody response to typhoid vaccination; its relationship to the intestinal IgA response. Immunology (1990) 0.96
Immunity in the invertebrates. I. Studies on the naturally occurring haemagglutinins in the fluid from invertebrates. Aust J Exp Biol Med Sci (1969) 0.95
Mechanism of inhibition of a poxvirus topoisomerase by the marine natural product sansalvamide A. Mol Pharmacol (1999) 0.94
Measurement of intestinal antibody by radioimmunoassay. Clin Exp Immunol (1980) 0.94
Postneonatal mortality surveillance--United States, 1980-1994. MMWR CDC Surveill Summ (1998) 0.94
Immunogenicity of a candidate live oral typhoid/cholera hybrid vaccine in humans. J Infect Dis (1989) 0.94
Antibodies in serum and secretions 1 year after salmonella gastroenteritis. Clin Exp Immunol (1982) 0.93
Self-efficacy and goal importance in the prediction of physical disability in people following hospitalization: a prospective study. Br J Health Psychol (2001) 0.92
Mechanisms of antibacterial immunity against Vibrio cholerae in the intestinal tracts of baby mice. J Infect Dis (1973) 0.91
The production of antibody to bovine serum albumin in unresponsive (Sobey) mice. Immunology (1968) 0.90
Selected antepartum medical complications and very-low-birthweight infants among black and white women. Am J Public Health (1994) 0.90
The effect of antibody on the intestinal absorption of macromolecules and on intestinal permeability in adult mice. Int Arch Allergy Appl Immunol (1982) 0.89
Antibacterial action of antibody and complement. J Infect Dis (1973) 0.88
The mechanism of complement fixation by rabbit F(ab')2: properties of the bactericidal reaction. Immunochemistry (1977) 0.87
The antibacterial efficiencies of ovine IgA, IgM, and IgG. J Infect Dis (1974) 0.87
The specificity of Vibrio cholerae adherence and the significance of the slime agglutinin as a second mediator of in vitro attachment. J Infect Dis (1983) 0.87
Local immunity to klebsiella pneumoniae in the lungs of mice. J Infect Dis (1983) 0.86
A comparison of methods for measuring intestinal antibodies against Vibrio cholerae in mice. Aust J Exp Biol Med Sci (1979) 0.86
Assays for total and antigen-specific polymeric IgA in serum based on binding to secretory component. J Immunol Methods (1989) 0.85
Intestinal absorption of bacterial antigens in normal adult mice. II. A comparative study of techniques. Int Arch Allergy Appl Immunol (1985) 0.85
The natural resistance of pigeons to type 3 pneumococcus. Aust J Exp Biol Med Sci (1969) 0.84
Clearance of bacteria from lungs of mice after opsonising with IgG or IgA. Aust J Exp Biol Med Sci (1979) 0.84
Specific immune antibacterial mechanisms in the intestines of mice. Am J Clin Nutr (1974) 0.83
Prevalence of human papillomavirus in men who have sex with men in the era of an effective vaccine; a call to act. HIV Med (2014) 0.83
Characterization and immunogenicity of EX880, a Salmonella typhi Ty21a-based clone which produces Vibrio cholerae O antigen. Infect Immun (1991) 0.83
Modifications of the local immune response to Vibrio cholerate attributed to the intestinal microbial flora of the mouse. Aust J Exp Biol Med Sci (1978) 0.83
The correlation between serum IgA antibody levels and resistance to infection with Salmonella typhimurium after oral immunization with various salmonellae. Aust J Exp Biol Med Sci (1985) 0.83
Intestinal antibody to Vibrio cholerae in immunised mice. Aust J Exp Biol Med Sci (1979) 0.82
Nonlipopolysaccharide protective antigens shared by classical and El Tor biotypes of Vibrio cholerae. J Infect Dis (1987) 0.82
Proceedings of "Workshop on Guidelines for Scene Investigation of Sudden Unexplained Infant Deaths"--July 12-13, 1993. J Forensic Sci (1994) 0.82
Immune responses to enterobacteria presented by various routes. Prog Allergy (1983) 0.81
Effect of cyclosporin A on the anti-leukaemia action associated with graft-versus-host disease. Br J Cancer (1983) 0.80
The problems of oral immunisation. Aust J Exp Biol Med Sci (1977) 0.80
In vitro degradation of mouse, rabbit and dog antibodies to Vibrio cholerae by succus entericus. Aust J Exp Biol Med Sci (1978) 0.80
Conjugated linoleic acid improves airway hyper-reactivity in overweight mild asthmatics. Clin Exp Allergy (2010) 0.80
Changes in the immunoglobulin levels of the mouse gut and serum during conventionalisation and following administration of Salmonella typhimurium. Aust J Exp Biol Med Sci (1978) 0.79
Surveillance of postneonatal mortality, United States, 1980-1987. MMWR CDC Surveill Summ (1991) 0.79
Adenovirus-mediated combination suicide and cytokine gene therapy for bladder cancer. Anticancer Res (2000) 0.79
Quantitative assay of a protein antigen of vibrio cholerae involved in the vibriocidal action of antibody and complement. Aust J Exp Biol Med Sci (1971) 0.79